Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; CDC Advisory Committee on Immunization Practices (ACIP). 2004 (May 28). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recommendations and Reports 53(RR-6):1–40.

IOM (Institute of Medicine). 2004. Learning from SARS: Preparing for the Next Disease Outbreak. 1st ed. Washington, DC: The National Academies Press.

Jefferson T, Demicheli V. 1998. Socioeconomics of influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. London, England: Blackwell Science. Pp. 541–547.

Kaufmann AF, Meltzer MI, Schmid GP. 1997. The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable? Emerg Infect Dis 3:83–94.

Kavet J. 1977. A perspective on the significance of pandemic influenza. Am J Public Health 67:1063–1070.

Kolata G. 1997 (March 21). Genetic material of virus from 1918 flu is found. New York Times. Sect. A. P. 2.

Krauss C. 2003 (April 26). The SARS epidemic: Toronto; Canada increases pressure on World Health Organization to lift travel advisory. New York Times. Sect. A. P. 8.

Longini IM Jr, Halloran ME, Nizam A, Yang Y. 2004. Containing pandemic influenza with antiviral agents. Am J Epidemiol 159(7):623–633.

McBean AM, Babish JD, Warren JL. 1993. The impact and cost of influenza in the elderly. Arch Intern Med 153:2105–2111.

Mullooly JP, Barker WH. 1982. Impact of type A influenza on children: A retrospective study. Am J Public Health 72:1008–1016.

Neustadt RE, Fineberg HV. 1978. The swine flu affair: Decision making on a slippery disease. Washington, DC: U.S. Department of Health, Education, and Welfare.

Neustadt R, Fineberg HV. 1983. The Epidemic That Never Was: Policy Making in the Swine Flu Scare. 1st ed. New York: Vintage Books.

Office of Technology Assessment, U.S. Congress. 1981. Cost Effectiveness of Influenza Vaccination. Washington, DC: Government Printing Office.

Patriarca PA, Cox NJ. 1997. Influenza pandemic preparedness plan for the United States. J Infect Dis 176(Suppl 1):S4–S7.

Patriarca PA, Arden NH, Koplan JP, Goodman RA. 1987. Prevention and control of type A influenza infections in nursing homes: Benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med 107:732–740.

Riddiough MA, Sisk JE, Bell JC. 1983. Influenza vaccination: Cost-effectiveness and public policy. JAMA 249:3189–3195.

Roberts S. 2003. Communicating with the public about public health preparedness. In: DIMACS Working Group on Modeling Social Responses to Bioterrorism Involving Infectious Agents. New Brunswick, NJ: Rutgers University.

Robinson LJ, Barry PJ. 1987. The Competitive Firm’s Response to Risk. New York: Macmillan.

Rosenberg CE. 1989. What is an epidemic?: AIDS in historical perspective. Daedalus 118(2):1–17.

Sandman PM. 1993. Responding to Community Outrage: Strategies for Effective Risk Communication. Fairfax, VA: American Industrial Hygiene Association.

Sandman PM, Lanard J. 2004 (October 22). Flu Vaccine Shortages: Segmenting the Audience. [Online]. Available: http://psandman.com/col/flu-1.htm.

Sapsin JW, Thompson TM, Stone L, DeLand KE. 2003. International trade, law, and public health advocacy. J Law Med Ethics 31(4):546–556.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement